Midgard Science

eXmoor Pharma

Bristol, United Kingdom exmoorpharma.com From their website, Nov 2026

  • GMP

Work here? Claim this listing

About

eXmoor Pharma is a cell and gene therapy CDMO that combines consultancy, process development, analytical services, GMP manufacturing, and facility design support. It serves biotech innovators, academic groups, biopharma companies, and investors from its Bristol, UK site, supporting development through commercialisation.

Services

  • CMC Consulting & Strategy

    Helps define CMC plans, align development with regulatory expectations, and create roadmaps for long-term success.

  • Cost of Goods

    Provides cost modelling to support manufacturing decisions, pricing strategy, market access, and scale-up planning.

  • Investor & Technical Due Diligence

    Assesses scientific, technical, regulatory, and commercial risks to support investment and acquisition decisions.

  • GMP Compliance Consulting & QP Services

    Provides GMP oversight, batch certification, inspection readiness, and compliance support through Qualified Persons.

  • Interim Leadership Positions

    Supplies interim executives and technical leaders to fill short-term leadership gaps in technical, regulatory, and manufacturing roles.

  • Process Development

    Optimises and scales cell and gene therapy processes for development, tech transfer, and commercialisation.

  • Analytical Services

    Generates analytical data to support product safety, efficacy, regulatory compliance, batch release, and stability studies.

  • GMP Manufacturing

    Provides regulatory-compliant GMP manufacturing for cell and gene therapy products.

5 more services
  • Facility Design & Process Engineering
  • Clinical Manufacturing
  • Commercial Manufacturing
  • Cell Banking
  • Fill Finish

Capabilities

Assays and studies
  • Process development
  • Cell therapy
  • Fill-finish
  • AAV
  • Bioreactors
  • Lentivirus
9 more
  • Analytical development
  • Physiochemical testing
  • Molecular testing
  • Biological testing
  • Potency testing
  • Sterility testing
  • Purity testing
  • Batch release testing
  • Stability studies
Scale and capacity
  • 65,000 ft² facility
  • 12,000 ft² planned expansion
  • Four independent Grade C clean rooms
  • 2 x 200L bioreactor scale
  • 5 autologous cell therapy stations
  • 500–1000L viral vector processes
Therapeutic areas
  • Cell and gene therapy
  • Advanced therapies

Instruments and platforms

  • Grade A isolators
  • QC laboratories

Modalities and species

Modalities
  • mRNA
  • Viral vector
  • Cell therapy
  • LNP / formulation
Species and models
iPSC / organoids

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

Details

Type
CRDMO
Founded
2004
Size
51-200 employees
Based in
Bristol, United Kingdom
Serves
Worldwide, global

Similar labs